EC as regards vaccination against bluetongue - Main contents

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier	COM(2011)943 - TO THE EUROPEAN PARLIAMENT pursuant to Article 294(6) of the Treaty on the Functioning of the EU concerning the position of ...
document	COM(2011)943
date	January 6, 2012

agreement, endorsed in the Competitiveness Council on 29 September 2011 and by the Conference of the Presidents of the European Parliament on 20 October 2011.

The Council has adopted its position at first reading on 15 December for a possible early second reading.

The opinion of the Economic and Social Committee was adopted on 15 March 2011 (NAT/512). The rapporteur is Mr Ludvík Jírovec.

2. OBJECTIVE OF THE PROPOSAL FROM THE COMMISSION

The aim of the Commission proposal is to offer more flexibility to vaccination against the bluetongue disease, in order to allow animals to be vaccinated also outside those areas subject to animal movement restrictions.

The Commission proposal thus amends Council Directive 2000/75/EC. Article 5 is amended so that competent authorities allow vaccination against bluetongue subject to a specific risk assessment. The amendment of Article 8(2) (b) of Directive 2000/75/EC will provide that within the surveillance zone no vaccination is carried out with "modified live attenuated" vaccines. Further, the proposal provides for the amendment of Article10 (2) of the Directive to the effect that the prohibition currently imposed against any vaccination within the surveillance zone, be limited to vaccination with "modified live attenuated" vaccines; and thus it allows vaccination with "inactivated vaccines", which are safer.

In addition the Commission proposal foresees that when Member States adopt the above provisions, they shall communicate to the Commission the text of those provisions and a correlation table between those provisions and the Directive.

3 . COMMENTS ON THE POSITION OF THE COUNCIL

The Council position is that Article 43(2) of TFEU should be used as legal base instead of the one proposed by the Commission because the Lisbon treaty introduced the ordinary legislative procedure for proposals based on Article 43. The Commission does not object to this change of legal base.

As the Council agrees to the possibility to vaccinate against bluetongue also outside those areas subject to animal movement restrictions, in line with the Commission proposal, the Commission supports the Council position.

Given the delays in the adoption of the proposal due to the inter-institutional debate on the issue of correlation tables, the Council intends to postpone the proposed dates of adoption and publication of the national laws, regulations and administrative provisions necessary to comply with this Directive and of application of those provisions. The Commission accepts this postponement which stays compatible with the next vaccination season.

With regard to the request for a correlation table for the present proposal, the Council is opposed to it. In light of the limited number of amendments proposed to an existing Directive transposed in national law since a decade, and the resulting easy check on their transposition, the Commission can accept that no provision on correlation tables is inserted in this Directive.

The European Parliament proposed amendments to the proposal, essentially modifying the legal base to Article 43(2), and introducing new implementation dates to ensure enforcement in time for the vaccination season. None of those amendments were controversial. However the inter-institutional discussions on the question of correlation tables blocked any progress on the proposal.

4. CONCLUSION

The Commission welcomes the Council position at first reading, which paves the way for an early second reading agreement.

[1] Council Directive 2000/75/EC of 20 November 2000 laying down specific provisions for the control and eradication of bluetongue (OJ L 327, 22.12.2000, p. 74).

[2] OJ L 62, 15.3.1993, p. 69.